This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Mitochondrial Neurogastrointestinal Encephalopathy Syndrome
Information about Mitochondrial Neurogastrointestinal Encephalopathy Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Mitochondrial Neurogastrointestinal Encephalopathy Syndrome
Most recent studies have shown that Mitochondrial Neurogastrointestinal Encephalopathy Syndrome shares some biological mechanisms with blepharoptosis, cachexia, chronic-progressive-external-ophthalmoplegia, encephalopathies, external-ophthalmoplegia, gastrointestinal-diseases, intestinal-pseudo-obstruction, leukoencephalopathies, melas-syndrome, mitochondrial-diseases, mitochondrial-dna-depletion, mitochondrial-encephalomyopathies, mitochondrial-myopathies, myopathy, ophthalmopareses, ophthalmoplegia, peripheral-neuropathy, pseudo-obstruction.
Among the many pathways, these few ones have gauged particular interests from scientists studying Mitochondrial Neurogastrointestinal Encephalopathy Syndrome, and have been seen in publications frequently: Cell Growth, Dna Replication, Electron Transport, Electron Transport Chain, Excretion, Immune Response, Inflammatory Response, Mitochondrial Dna Replication, Muscle Atrophy, Oxidative Phosphorylation, Pathogenesis, Transport
Quite a number of genes have been found to play important roles in Mitochondrial Neurogastrointestinal Encephalopathy Syndrome, such as ASXL1, CYCS, DGUOK, LCN1, MPV17, NPTX2, PAFAH1B1, POLG, POLG2, PRPF6, RRM2B, S1PR1, SF3B1, SLC25A4, TK1, TK2, TMPO, TYMP, YWHAE. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.